Abstract
In the present study we investigated the effect of chronic variable stress (CVS) on some parameters of the immune system, including levels of cytokines [interleukin 1β (IL-1 β), interleukin 6 (IL-6), tumor necrosis factor α (TNF- α)] and chemokine CCL2 (MCP-1) in the hippocampus of rats. Acetylcholinesterase activity was also evaluated. Sixty-day old Wistar rats were submitted to different mild stressors for 40 days. After the last stress section, the cytokines and MCP-1 were determined by immunoassay and acetylcholinesterase activity by colorimetric method. Results showed that chronic stress significantly increased the levels of IL-1β, IL-6 and TNF-α, but did not alter the levels of MCP-1. In addition, acetylcholinesterase activity was increased in the hippocampus of rats subjected to CVS. These findings suggest that inflammation and cholinergic dysfunction may be, at least in part, important contributors to the neurological dysfunction observed in some depressed patients.
Similar content being viewed by others
References
Skilbeck KJ, Johnston GA, Hinton T (2010) Stress and GABA receptors. J Neurochem 112(5):1115–1130
Licinio J, Wong M (2005) Biology of depression, 1st edn. WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany
Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351–1362
Munhoz CD, García-Bueno B, Madrigal JLM et al (2008) Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz J Med Biol Res 41:1037–1046
Sorrels SF, Sapolski RM (2008) An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 21(3):259–272
Alesci S, Martinez PE, Kelkar S et al (2005) Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 90:2522–2530
Schlatter J, Ortuño F, Cervera-Enguix S (2004) Monocytic parameters in patients with dysthymia versus major depression. J Affect Disord 78:243–247
Tiemeier H, Hofman A, van Tuijl HR et al (2003) Inflammatory proteins and depression in the elderly. Epidemiology 14:103–107
Danner M, Kasl SV, Abramson JL et al (2003) Association between depression and elevated C-reactive protein. Psychosom Med 65:347–356
Steptoe A, Kunz-Ebrecht SR, Owen N (2003) Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 33:667–674
Haack M, Hinze-Selch D, Fenzel T et al (1999) Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 33:407–418
Owen BM, Eccleston D, Ferrier IN et al (2001) Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand 103:226–228
Darvesh S, Hopkins DA, Geula C (2003) Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 17:131–138
Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB) (1992) Enzyme nomenclature. Academic Press, San Diego
Borovikova LV, Ivanova S, Zhang M et al (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458–462
Srikumar BN, Raju TR, Shankaranarayana Rao BS (2006) The involvement of cholinergic and noradrenergic systems in behavioral recovery following oxotremorine treatment to chronically stressed rats. Neuroscience 143:679–688
Mizoguchi K, Yuzurihara M, Ishige A et al (2001) Effect of chronic stress on cholinergic transmission in rat hippocampus. Brain Res 915:108–111
Sunanda GV, Shankaranarayana Rao BS, Raju TR (2000) Restraint stress-induced alterations in the levels of biogenic amines, amino acids, and AChE activity in the hippocampus. Neurochem Res 25:1547–1552
Lorenzetti V, Allen NB, Fornito A et al (2009) Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord 117(1–2):1–17
Wayne C, Drevets JL, Price M (2008) Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213:93–118
Gamaro GD, Manoli LP, Torres ILS et al (2003) Effects of chronic variate stress on feeding behavior and on monoamine levels in different rat brain structures. Neurochem Int 42:107–114
Marin MT, Cruz FC, Planeta CS (2007) Chronic restraint or variable stresses differently affect the behavior, corticosterone secretion and body weight in rats. Physiol Behav 90(1):29–35
Porsolt RD, Bertin A, Jalfre M (1997) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336
Harro J, Tõnissaar M, Eller M et al (2001) Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry. Brain Res 899(1–2):227–239
Konarska M, Stewart RE, McCarty R (1990) Predictability of chronic intermittent stress: effects on sympathetic-adrenal medullary responses of laboratory rats. Behav Neural Biol 53:231–243
Froger N, Palazzo E, Boni C (2004) Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J Neurosci 24(11):2787–2796
Ellman GL, Courtney KD, Andres V Jr (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Bradford MM (1976) A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principle of protein-diebinding. Anal Biochem 72:248–254
Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–267
Kessler RC, McGonagle KA, Zhao S et al (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–19
Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90–110
Elizalde N, Pastor PM, Garcia-García AL et al (2010) Regulation of markers of synaptic function in mouse models of depression: chronic mild stress and decreased expression of VGLUT1. J Neurochem 114(5):1302–1314
Mao QQ, Xian YF, Xian YF, Ip SP et al (2010) Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain. Behav Brain Res 210(2):171–177
Rezin GT, Gonçalves C, Daufenbach JF et al (2009) Acute administration of ketamine reverses the inhibition of mitochondrial respiratory chain induced by chronic mild stress. Brain Res Bull 79:418–421
Willner P (1997) The chronic mild stress model of depression: valid, reasonably reliable, and useful. Psychopharmacology 134:371–377
Grippo AJ, Sullivan NR, Damjanoska KJ et al (2005) Chronic mild stress induces behavioural and physiological changes, and may alter serotonin 1A receptor function in male and cycling female rats. Psychopharmacology 179:769–780
Benelli A, Filaferro M, Bertonili A et al (1999) Influence of S-adenosyl- L -carnitine on chronic mild stress-induced anhedonia in castrated rats. Braz J Pharmacol 127:645–654
Nielsen CK, Arnt J, Sanchez C (2000) Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and inter-individual differences. Behav Brain Res 107:21–33
Moreau JL, Scherschlict R, Jenck F et al (1995) Chronic mild stress-induced anhedonia model of depression: sleep abnormalities and curative effects of electroshock treatment. Behav Pharmacol 6:682–687
Gronli J, Murison R, Fiske E et al (2003) Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions. Physiol Behav 84:571–577
Brotto LA, Gorzalka BB, LaMarre AK (2001) Melatonin protects against the effects of chronic stress on sexual behaviour in male rats. Neuroreport 12:3465–3469
Tagliari B, dos Santos TM, Cunha AA et al (2010) Chronic variable stress induces oxidative stress and decrease butyrylcholineterase activity in blood of rats. Neural Transm 117(9):1067–1076
Bielajew C, Konkle AT, Mentne AC et al (2003) Strain and gender specific effects in the forced swim tests: effects of previous stress exposure. Stress 6:269–280
Fujisaki C, Utsuyama M, Kuroda Y (2002) An immunosuppressive drug, cyclosporine-A acts like anti-depressant for rats under unpredictable chronic stress. J Med Dent Sci 50:93–100
Cheeta S, Ruigt G, van Proosdij J et al (1997) Changes in sleep architecture following chronic mild stress. Biol Psychiatry 41:419–427
O’Connor KA, Johnson JD, Hansen MK et al (2003) Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res 991(1–2):123–132
Mormède C, Castanon N, Médina C et al (2003) Chronic mild stress in mice decreases peripheral cytokine and increases central cytokine expression independently of IL-10 regulation of the cytokine network. Neuroimmunomodulation 10(6):359–366
Nguyen KT, Deak T, Owens SM et al (1998) Exposure to acute stress induces brain interleukin-1β protein in the rat. J Neurosci 19:2799–2805
Hanisch UK (2002) Microglia as a source and target of cytokines. Glia 40:140–155
Breder CA, Tsujimoto M, Terano Y et al (1993) Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine and central nervous system. J Comp Neurol 337:543–567
Miyahara S, Komori T, Fujiwara R et al (2000) Effects of repeated stress on expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat hypothalamus and midbrain. Life Sci 66:PL93–PL98
Lee M, Cho T, Jantaratnotai N, Wang YT et al (2010) Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J 24(7):2533–2545
Innamorato NG, Lastres-Becker I, Cuadrado A (2009) Role of microglial redox balance in modulation of neuroinflammation. Curr Opin Neurol 22(3):308–314
Hensley K, Mhatre M, Mou S et al (2006) On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid Redox Signal 8(11–12):2075–2087
De A, Krueger JM, Simasko SM (2005) Glutamate induces the expression and release of tumor necrosis factor-alpha in cultured hypothalamic cells. Brain Res 1053(1–2):54–61
Rogove AD, Tsirka SE (1998) Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr Biol 8(1):19–25
Nair A, Bonneau RH (2006) Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol 171:72–85
Frank MG, Baratta MV, Sprunger DB et al (2006) Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 21:47–59
Lucca G, Comim CM, Valvassori SS et al (2009) Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int 54:358–362
Vasconcellos APS, Nieto FB, Crema LM et al (2006) Chronic lithium treatment has antioxidant properties but does not prevent oxidative damage induced by chronic variate stress. Neurochem Res 31:1141–1151
Madrigal JL, Garcia-Bueno B, Hinojosa AE et al (2010) Regulation of MCP-1 production in brain by stress and noradrenaline-modulating drugs. J Neurochem 113:543–551
McEwen BS (2001) Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci 933:265–277
Sapolsky RM (2000) The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48:755–765
Moghaddam B (1993) Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 60:1650–1657
Luo L, Tan RX (2001) Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model. Acta Pharmacol Sin 22:865–870
Madrigal JLM, Olivenza R, Moro MA et al (2001) Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 24(4):420–429
Little AR, Sriram K, O’Callaghan JP (2006) Corticosterone regulates expression of CCL2 in the intact and chemically injured hippocampus. Neurosci Lett 399:162–166
Rada P, Colasante C, Skirzewski M et al (2006) Behavioral depression in the swim test causes a biphasic, long-lasting change in accumbens acetylcholine release, with partial compensation by acetylcholinesterase and muscarinic-1 receptors. Neuroscience 141:67–76
Müller TC, Rocha JBC, Morsch VM et al (2002) Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activity. Biochim Biophys Acta 1587:92–98
Barcellos CK, Schetinger MRC, Dias RD et al (1998) In vitro effect of central nervous system active drugs on the ATPase-ADPase activity and acetylcholinesterase activity from cerebral cortex of adult rats. Gen Pharmacol 31:563–567
Acknowledgments
This work was supported in part by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq—Brazil) and Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tagliari, B., Tagliari, A.P., Schmitz, F. et al. Chronic Variable Stress Alters Inflammatory and Cholinergic Parameters in Hippocampus of Rats. Neurochem Res 36, 487–493 (2011). https://doi.org/10.1007/s11064-010-0367-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-010-0367-0